Increased HVEM surface expression and high levels of sBTLA correlated with decreased overall survival (OS) and time to treatment (TTT) suggesting a role of BTLA/HVEM in the pathogenesis of CLL. The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.